“kidney-cancer” Archives

Entry Author Date Location
Bio Roundup: Frazier v. Trump, Data Dumps, New York Steps & More 08/18/17 National
Latest Immunotherapy Setback: Bristol Drugs Stumble in Kidney Cancer 08/16/17 New York
Bio Roundup: Trump Backlash, Verdine Plans, Sarepta Sale & More 02/24/17 National
Roundup: DIUx, Scraffic, Peloton, Pitchocracy, & Alamo City Angels 09/19/16 Texas
Dallas-Based Peloton Raises $52.4M for Kidney Cancer Drug Candidate 09/15/16 Texas
East Coast Biotech Roundup: Regeneron, Sage, Tara, Alnylam, & More 11/14/14 Boston
East Coast Biotech Roundup: Dicerna, J&J, Neurophage, & More 01/31/14 Boston
Lessons For Drug Development From The Aveo Buzzsaw 05/06/13 National
Aveo Shares Plummet as FDA Advisory Panel Votes Down Cancer Drug 05/02/13 Boston
Aveo (Barely) Passes Study With Kidney Cancer Drug, Stock Falls 01/03/12 Boston
Antigenics Expands Experimental Cancer Treatment, Novartis Adds to Cambridge Presence, Boston Scientific Sells Unit to Stryker, & More Boston-Area Life Sciences News 10/29/10 Boston
Antigenics, and its UCSF Champion, Stick With Immune Booster For Brain Cancer 10/25/10 Boston
Aveo Pharma Stock Jumps 40 Percent in A Week, CEO Notes Progress in Pivotal Kidney Cancer Trial 08/31/10 Boston
Aveo Pharmaceuticals Eyes $86.3M IPO 12/17/09 Boston
Antigenics Shares Plummet as Cancer Vaccine Application Rejected in Europe 10/21/09 Boston
Aveo Pieces Together a Plan to Rival Big Boys of Cancer Drug World 06/29/09 Boston
ZymoGenetics Kidney Cancer Drug Shrinks, Stabilizes Tumors in Sickest Patients 05/31/09 Seattle
Aveo Kidney Cancer Drug, Challenging Pfizer and Bayer, Passes Important Test 05/29/09 Boston
ZymoGenetics Takes Back Full Rights to Cancer Drug Candidate 01/28/09 Seattle
Antigenics Asks European Regulators to Approve Oncophage for Kidney Cancer 10/22/08 Boston
Page 1 of 1